Abstract
Purpose
To evaluate the effect of Terazosin (α1 adrenergic blocker) on bladder emptying in children with posterior urethral valves.
Materials and methods
Forty-two children with significant post void residual urine after valves ablation were placed on Terazosin ranging from 0.25 to 2 mg. Post void urine at the commencement and at follow up was monitored with abdominal ultrasound.
Results
Post void residual urine significantly reduced in 40 patients (95%) who were put on Terazosin. Mean pretreatment PVR was 15.7 ml and mean PVR at the last follow up was 2.4 ml (P = 0.000). This was a reduction of 85% in the pretreatment post void residual urine volume. All the patients had improvement in urinary stream. One patient reacted to Terazosin with hypotension necessitating its withdrawal. Mean follow up was 17 months.
Conclusion
Terazosin has proved to be safe and results in significant improvement in bladder emptying in our patients with posterior urethral valves. Randomized controlled trial and long-term follow up are necessary to further define the role of α1 adrenergic blocker therapy in children with posterior urethral valves. This study will become the justification for such a study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Imaji R, Moon D, Dewan PA (2003) Newborn surgery. In: Puri P (ed) Posterior urethral valves, 2nd edn. Arnord, London, pp 853–866
Elder JS (2003) Management of antenatally detected hydronephrosis. In: Puri P (ed) Newborn surgery, 2nd edn. London, Arnold, pp 793–808
Joseph DB (2000) Editorial: posterior urethral valves and the 11th commandment. J Urol 164:149
Greenfield SE (1997) Editorial: posterial urethral valves. J Urol 157:996
Basak D (2003) Editorial: posterior urethral valves—an Enigma. J Ind Assoc Pead Surg 8:130
Koff SA (1983) Estimating bladder capacity in children. Urology 21:248
Abraham MK (1990) Mohan’s valvotome: a new instrument. J Urol 144:1196
Anderson KE (1997) The overactive bladder. Urology 50:70
Anderson KE (1998) Pharmacology basis of drug treatment. Eur Urol 33:7
Moore CK, Leendusky M, Longhurst PA (2002) Relationship of mass of obstructed rat bladders and responsivenes to adrenergic stimulation. J Urol 168:1621
Restorick JM, Mundy AR (1989) The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyperreflexic human detrusor. Br J Urol 63:32
Grahame-Smith DG, Aronson JK (eds) (2002) Oxford textbook of clinical pharmacology and drug therapy, 3rd edn. Oxford university press, New York
Austin PF, Homsy YL, Masel JL, Cain MP, Casle AJ, Rnk RC (1999) α adrenergic blockade in children with neuropathic and non-neuropathic voiding dysfunction. J Urol 162:1064
Cain MP, Wu SD, Austin PF, Anthony CD, Rnk RC (2003) α adrenergic blockade for children with dysfunctional voiding and urinary retention. J Urol 170:1514
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abraham, M.K., Nasir, A.R.A., Sudarsanan, B. et al. Role of alpha adrenergic blocker in the management of posterior urethral valves. Pediatr Surg Int 25, 1113–1115 (2009). https://doi.org/10.1007/s00383-009-2469-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-009-2469-9